Every day we scan the headlines for the best items that engage the clinical trial ecosystem, workflow solutions, and more—all the latest news you need to know. Here are today's stories:

‍

A dengue vaccine is set for distribution in Indonesia next year. Dengue, a mosquito-borne illness, accounts for 400 million yearly infections worldwide, and over 20,000 deaths. Some researchers argue the new dengue vaccine is a safety concern. (Nature)

Kronos Bio suspended a phase 3 study of its leukemia therapeutic entospletinib. The trial was to enroll 180 participants across several countries, but was ended due to enrollment issues. (Fierce Biotech)

Supported by the Australian government under the Medical Research Future Fund, Australia has launched the Australian Teletrial Program to increase access to clinical trials for patients with limited access to medical facilities.
(ABC North Queensland)

The CNS Summit 2022 will be held on November 17–20, in Boca Raton, Florida. Created as "a community of innovators and industry leaders who are not afraid to challenge the status quo," CNS was founded in 2009 to advance clinical development, focused on collaboration and innovation. Team AG Mednet will be there!

‍

‍

‍

Our Culture

“The final product that the client receives is fully configured to their trial, their forms, their workflow.”

 –Jess, Program Manager
‍

‍‍

‍

‍

About Judi

Judi speeds and improves the world's clinical trial workflows. Our cloud-based platform has 120,000 users across 168 countries. We eliminate the chaos so clinical teams can focus on the patient, rather than the process. We are a SOC 2 Type II certified collaboration platform.